Vittal Vasista is Chief Financial Officer of REGENXBIO Inc.. Currently has a direct ownership of 246,534 shares of RGNX, which is worth approximately $2.45 Million. The most recent transaction as insider was on Mar 19, 2024, when has been sold 20,041 shares (Common Stock) at a price of $3.76 per share, resulting in proceeds of $75,354. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 247K
0% 3M change
14.67% 12M change
Total Value Held $2.45 Million

Vittal Vasista Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2024
BUY
Exercise of conversion of derivative security
$75,354 $3.76 p/Share
20,041 Added 7.52%
246,534 Common Stock
Jan 02 2024
SELL
Payment of exercise price or tax liability
$81,385 $17.95 p/Share
4,534 Reduced 2.11%
210,467 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
16,026 Added 6.61%
226,493 Common Stock
May 31 2023
BUY
Exercise of conversion of derivative security
$29,750 $0.85 p/Share
35,000 Added 14.0%
215,001 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$30,232 $22.68 p/Share
1,333 Reduced 0.99%
133,827 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
46,174 Added 20.42%
180,001 Common Stock
Aug 30 2022
SELL
Open market or private sale
$72,576 $30.24 p/Share
2,400 Reduced 1.74%
135,160 Common Stock
Aug 05 2022
SELL
Open market or private sale
$608,083 $35.19 p/Share
17,280 Reduced 11.16%
137,560 Common Stock
Aug 04 2022
SELL
Open market or private sale
$14,000 $35.0 p/Share
400 Reduced 0.26%
154,840 Common Stock
Aug 01 2022
SELL
Open market or private sale
$75,000 $31.25 p/Share
2,400 Reduced 1.52%
155,240 Common Stock
Jul 14 2022
SELL
Open market or private sale
$14,040 $30.0 p/Share
468 Reduced 0.3%
157,640 Common Stock
Jul 13 2022
SELL
Open market or private sale
$130,003 $30.01 p/Share
4,332 Reduced 2.67%
158,108 Common Stock
Jan 20 2022
BUY
Exercise of conversion of derivative security
$25,415 $0.85 p/Share
29,900 Added 15.55%
162,440 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
8,900 Added 6.29%
132,540 Common Stock
Jul 27 2021
BUY
Exercise of conversion of derivative security
$8,500 $0.85 p/Share
10,000 Added 7.48%
123,640 Common Stock
Jan 15 2021
SELL
Open market or private sale
$12,610 $50.04 p/Share
252 Reduced 0.22%
113,640 Common Stock
Jan 14 2021
SELL
Open market or private sale
$554,983 $50.03 p/Share
11,093 Reduced 8.88%
113,892 Common Stock
Jan 12 2021
SELL
Open market or private sale
$210,042 $50.01 p/Share
4,200 Reduced 3.25%
124,985 Common Stock
Jan 08 2021
SELL
Open market or private sale
$248,214 $47.36 p/Share
5,241 Reduced 3.9%
129,185 Common Stock
Jan 07 2021
SELL
Open market or private sale
$549,900 $50.0 p/Share
10,998 Reduced 7.56%
134,426 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
12,400 Added 7.86%
145,424 Common Stock
Dec 24 2020
SELL
Open market or private sale
$168,800 $50.0 p/Share
3,376 Reduced 2.48%
133,024 Common Stock
Dec 23 2020
SELL
Open market or private sale
$1,056,411 $50.01 p/Share
21,124 Reduced 13.41%
136,400 Common Stock
Dec 11 2020
SELL
Open market or private sale
$599,176 $40.17 p/Share
14,916 Reduced 8.65%
157,524 Common Stock
Dec 10 2020
SELL
Open market or private sale
$904,715 $40.06 p/Share
22,584 Reduced 11.58%
172,440 Common Stock
VV

Vittal Vasista

Chief Financial Officer
Rockville, MD

Track Institutional and Insider Activities on RGNX

Follow REGENXBIO Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

News

Receive news related to REGENXBIO Inc.

Track Activities on RGNX